CAMBRIDGE, Mass. & BATH, United Kingdom, January 5, 2018 – Atlas Genetics, a rapid, near-patient and point-of-care (POC) testing company, today announced that it has appointed Stanley Lapidus to the…
CAMBRIDGE, Mass., December 12, 2017 – Atlas Genetics, a rapid, near-patient and point-of-care (POC) testing company, today announced the appointment of industry veteran Marc Jones as Chief Operating Officer (“COO”)…
Expanded Board and Blue Chip Investors Position Company for Global Reach Bath, UK, 3 October, 2017. Atlas Genetics Ltd., the ultra-rapid, point-of-care (POC) testing company for women’s and family health,…
Project to support adoption of the io® rapid diagnostic platform into UK sexual health clinics Bath, UK, 14 August, 2017. Atlas Genetics Ltd., the ultra-rapid Point-Of-Care (POC) molecular diagnostics company,…
Financing global launch and menu development of Atlas Genetics’ io® molecular testing system Bath, UK, 23 January, 2017. Atlas Genetics Ltd., the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces…
CE-marked CT test gives results in 30 minutes Bath, UK, 02 June 2016. Atlas Genetics Ltd (“Atlas Genetics” or the “Company”), the STI Point-Of-Care (POC) molecular diagnostics company, today notes…
